LAG3 Expression in Triple Negative Breast Cancer
NCT06259162
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
128
Enrollment
OTHER
Sponsor class
Conditions
Triple Negative Breast Cancer
Immune Checkpoint Inhibitor
Interventions
PROCEDURE:
LAG-3 expression / immune checkpoint protein expression
Sponsor
Samsung Medical Center